Webinar on

Bioavailability and Bioequivalence

March 30, 2021

bioavailability-bioequivalence-march

Theme: Advanced approaches in bioavailability and bioequivalence

Webinar on Bioavailability and Bioequivalence welcomes each one of you to attend a global conference in the field of Pharmacy which is held on March 30, 2021. The webinar emphasizes the theme “Advanced approaches in bioavailability and bioequivalence”. BABE Webinar provides an international dais for Scientists and Pharmaceutical professionals to Exchange Ideas, Knowledge and Networking. Knowledge of drug metabolism is useful in both the design of new drugs and the improvement of existing drugs. This is the platform for exchanging your ideas and learn novel concepts related to your field from the international speakers as well as the professionals participating in this symposium.

Session 1: Drug metabolism
One of the most challenging advanced research areas in pharmacology with in the new millennium is to know why every individual respond differently to drug therapy and to what extent that individual variability in disposition is liable for the observed differences in therapeutic efficacy and adverse reactions. Drug metabolism reactions are of two stages: stage 1 (functionalization) reactions like oxidation.
Bioavailability and Bioequivalence Webinar Bioavailability and Bioequivalence Congress Bioavailability Meeting Bioavailability Webinars Bioavailability Events Bioavailability and Bioequivalence Workshops

 

Session 2: Absolute & Relative bioavailability 
Absolute Bioavailability Compares the bioavailability of the active drug in systemic circulation following Non-intravenous administration with an equivalent drug following intravenous administration for drugs administered intravenously, bioavailability is 100%. Determination of the best administration route.
Relative Bioavailability compares the bioavailability of a formulation (A) of particular drug in comparison with another formulation (B) of an equivalent drug.
Bioavailability and Bioequivalence Webinar Bioavailability and Bioequivalence Congress Bioavailability Meeting Bioavailability Webinars Bioavailability Events Bioavailability and Bioequivalence Workshops

 

Session 3: Factors affecting Bioavailability of a Drug 
Factors affecting bioavailability are differentiated into pharmaceutical and pharmacological factors. By disintegration, dissolution and absorption the bioavailability of drugs to be in this decreasing order. Pharmaceutical factors are particle size, nature of excipients and adjuvants, degree of ionization. Pharmacological factors are gastric emptying and gastrointestinal motility, gastro intestinal diseases, food and other substances, first pass metabolism, drug-drug interactions, and route of administration.     

Bioavailability and Bioequivalence Webinar Bioavailability and Bioequivalence Congress Bioavailability Meeting Bioavailability Webinars Bioavailability Events Bioavailability and Bioequivalence Workshops

 

Session 4: First pass metabolism
The first pass effect is a phenomenon in which a drug gets metabolized at a specific location in the body that results in a reduced concentration of the active drug upon reaching its site of action or the circulation. The first pass effect is usually related to the liver, as this is often a serious site of metabolism. Let’s take a example of 100 drug molecules that are ingested in pill form. Only 90 of those molecules survive the alimentary canal. Then 81 make it past the gut wall and into the hepatic portal vein. Of the 81 that enters the liver, only 41 can make it to the systemic circulation.
Bioavailability and Bioequivalence Webinar Bioavailability and Bioequivalence Congress Bioavailability Meeting Bioavailability Webinars Bioavailability Events Bioavailability and Bioequivalence Workshops

 

Session 5Concept of Equivalents & Pharmaceutical equivalents
Pharmaceutical equivalents are drug products in identical dosage forms and route(s) of administration that contain identical amounts of the identical active drug ingredient, i.e., an equivalent salt or ester of the same therapy moiety, or, with in the case of modified-release dosages that need a reservoir, such forms as prefilled syringes where the volume may vary, that delivers identical amounts of the active ingredient over the identical dosing period; it don't necessarily contain an equivalent inactive ingredients.
Bioavailability and Bioequivalence Webinar Bioavailability and Bioequivalence Congress Bioavailability Meeting Bioavailability Webinars Bioavailability Events Bioavailability and Bioequivalence Workshops

Bioavailability-bioequivalence 2021 bring together collect specialists like eminent scientists, senior/junior analysis fellows, professors, students, members of the various medical and clinical associations, medicine and medical technology companies from everywhere the world to share an interest in the field of bioavailability-bioequivalence to discuss the new ideas and research ideas with developments within the field which is to be applied in close to future for the prosperity of humans. The event of latest techniques of diagnosing, treatment, and prevention should be recognized which is able to imply a big role within the lives of individuals. The distributed findings and researches relating to this subject are given another priority as these ar the stepping stones for the future.

  • Drug metabolism
  • Absolute & Relative bioavailability
  • Factors affecting Bioavailability of a Drug
  • First pass metabolism
  • Concept of Equivalents & Pharmaceutical equivalents

3 Renowned Speakers

KATERYNA ZUPANETS

National University of Pharmacy
Ukraine

INWOOK CHOI

Korea Food Research Institute
South Korea

YUAN CHEN

Genentech
United States of America

Media Partners & Collaborations

Media Partner

Media Partner

Media Partner

Media Partner

Media Partner